Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.76 USD | -0.13% | -6.18% | +33.33% |
07:05pm | Oppenheimer Adjusts Price Target on Viracta Therapeutics to $11 From $13, Maintains Outperform Rating | MT |
May. 14 | Viracta Therapeutics Appoints Michael Faerm CFO | MT |